Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 4:04 pm Sale | 13G | KEZAR LIFE SCIENCES INC KZR | Cormorant Asset Management LP | 0 0% | -1,422,911 (Position Closed) | View |
2020-02-14 4:03 pm Sale | 13G | AVROBIO INC AVRO | Cormorant Asset Management LP | 317,579 1% | -1,040,205 (-76.61%) | View |
2020-02-14 4:02 pm Sale | 13G | MIRATI THERAPEUTICS INC MRTX | Cormorant Asset Management LP | 1,782,392 4.15% | -367,608 (-17.10%) | View |
2020-02-14 4:02 pm Sale | 13G | INFLARX N V COM IFRX | Cormorant Asset Management LP | 0 0% | -2,890,100 (Position Closed) | View |
2020-02-14 4:02 pm Unchanged | 13G | CONSTELLATION PHARMACEUTICALS CNST | Cormorant Asset Management LP | 2,300,000 5.52% | 0 (Unchanged) | View |
2020-02-14 4:02 pm Purchase | 13G | PRINCIPIA BIOPHARMA INC PRNB | Cormorant Asset Management LP | 1,990,922 6.07% | 516,560 (+35.04%) | View |
2020-01-10 4:10 pm Purchase | 13G | CHEMOCENTRYX INC CCXI | Cormorant Asset Management LP | 3,386,208 5.41% | 86,208 (+2.61%) | View |
2019-12-16 5:05 pm Purchase | 13G | CHEMOCENTRYX INC CCXI | Cormorant Asset Management LP | 3,300,000 5.66% | 3,300,000 (New Position) | View |
2019-11-18 4:28 pm Purchase | 13G | CONSTELLATION PHARMACEUTICALS CNST | Cormorant Asset Management LP | 2,300,000 5.21% | 1,028,313 (+80.86%) | View |
2019-11-18 4:26 pm Purchase | 13G | NEXTCURE INC NXTC | Cormorant Asset Management LP | 1,428,577 5.27% | 1,428,577 (New Position) | View |
2019-11-14 4:04 pm Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | Cormorant Asset Management LP | 2,150,000 5.45% | 398,301 (+22.74%) | View |
2019-11-07 5:18 pm Purchase | 13G | CABALETTA BIO INC CABA | Cormorant Asset Management LP | 2,119,132 9% | 2,119,132 (New Position) | View |
2019-07-01 4:10 pm Purchase | 13G | STOKE THERAPEUTICS INC STOK | Cormorant Asset Management LP | 1,869,680 5.73% | 1,869,680 (New Position) | View |
2019-05-20 4:42 pm Purchase | 13G | HEALTH SCIENCES ACQUISITIONS C HSAC | Cormorant Asset Management LP | 1,080,000 7.51% | 1,080,000 (New Position) | View |